The History of Dermatology and Dermatologists at the US Food and Drug Administration

Vanessa L Burrows; Markham C Luke

doi:10.1016/j.det.2022.03.001

The History of Dermatology and Dermatologists at the US Food and Drug Administration

Dermatol Clin. 2022 Jul;40(3):237-248. doi: 10.1016/j.det.2022.03.001.

Authors

Vanessa L Burrows¹, Markham C Luke²

Affiliations

¹ History Office, U.S Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Electronic address: vanessa.burrows@fda.hhs.gov.
² Division of Therapeutic Performance, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

PMID: 35750408
DOI: 10.1016/j.det.2022.03.001

Abstract

In the United States, the Food and Drug Administration's (FDA's) regulatory authorities have significantly influenced the products available to treat dermatologic conditions, but at the same time, advances in dermatology have also influenced the FDA's approach, including the agency's evaluation of risks and its' communications to consumers, patients, and providers. This essay reviews significant milestones in the history of FDA's regulation of dermatologic products, with attention paid to significant products, impactful legal changes, and key personnel and organizational changes.

Keywords: Dermatologists; Dermatology; Food and Drug Administration; History; Regulation.

Published by Elsevier Inc.

Publication types

Review

MeSH terms

Dermatologists*
Dermatology*
Humans
United States
United States Food and Drug Administration